Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Photocatalytic Degradation of Azithromycin by Nanostructured TiO₂ Film: Kinetics, Degradation Products, and Toxicity.

Čizmić M, Ljubas D, Rožman M, Ašperger D, Ćurković L, Babić S.

Materials (Basel). 2019 Mar 15;12(6). pii: E873. doi: 10.3390/ma12060873.

2.

Using Low-Frequency Oscillations to Detect Temporal Lobe Epilepsy with Machine Learning.

Hwang G, Nair VA, Mathis J, Cook CJ, Mohanty R, Zhao G, Tellapragada N, Ustine C, Nwoke OO, Rivera-Bonet C, Rozman M, Allen L, Forseth C, Almane DN, Kraegel P, Nencka A, Felton E, Struck AF, Birn R, Maganti R, Conant LL, Humphries CJ, Hermann B, Raghavan M, DeYoe EA, Binder JR, Meyerand E, Prabhakaran V.

Brain Connect. 2019 Mar;9(2):184-193. doi: 10.1089/brain.2018.0601.

PMID:
30803273
3.

Carcinocythaemia in an advanced stage of invasive ductal carcinoma of the breast.

Oliver-Caldes A, Gonzalez-Farre B, Merino A, Rozman M.

Br J Haematol. 2018 Nov 26. doi: 10.1111/bjh.15678. [Epub ahead of print] No abstract available.

PMID:
30474859
4.

Effective Connectivity Within the Default Mode Network in Left Temporal Lobe Epilepsy: Findings from the Epilepsy Connectome Project.

Cook CJ, Hwang G, Mathis J, Nair VA, Conant LL, Allen L, Almane DN, Birn R, DeYoe EA, Felton E, Forseth C, Humphries CJ, Kraegel P, Nencka A, Nwoke O, Raghavan M, Rivera-Bonet C, Rozman M, Tellapragada N, Ustine C, Ward BD, Struck A, Maganti R, Hermann B, Prabhakaran V, Binder JR, Meyerand ME.

Brain Connect. 2019 Mar;9(2):174-183. doi: 10.1089/brain.2018.0600.

PMID:
30398367
5.

Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia.

Giménez N, Martínez-Trillos A, Montraveta A, Lopez-Guerra M, Rosich L, Nadeu F, Valero JG, Aymerich M, Magnano L, Rozman M, Matutes E, Delgado J, Baumann T, Gine E, González M, Alcoceba M, Terol MJ, Navarro B, Colado E, Payer AR, Puente XS, López-Otín C, Lopez-Guillermo A, Campo E, Colomer D, Villamor N.

Haematologica. 2019 Mar;104(3):576-586. doi: 10.3324/haematol.2018.196931. Epub 2018 Sep 27.

6.

Extraction and cleansing of data for a non-targeted analysis of high-resolution mass spectrometry data of wastewater.

Verkh Y, Rozman M, Petrovic M.

MethodsX. 2018 Apr 17;5:395-402. doi: 10.1016/j.mex.2018.04.008. eCollection 2018.

7.

Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes.

Alvarez-Larran A, Martínez D, Arenillas L, Rubio A, Arellano-Rodrigo E, Hernández Boluda JC, Papaleo N, Caballero G, Martínez C, Ferrer-Marín F, Mata MI, Pérez-Encinas M, Durán MA, Alonso JM, Carreño-Tarragona G, Alonso JM, Noya S, Magro E, Pérez R, López-Guerra M, Pastor-Galán I, Cervantes F, Besses C, Colomo L, Rozman M.

J Clin Pathol. 2018 Nov;71(11):975-980. doi: 10.1136/jclinpath-2018-205227. Epub 2018 Jun 22.

PMID:
29934356
8.

A non-targeted high-resolution mass spectrometry data analysis of dissolved organic matter in wastewater treatment.

Verkh Y, Rozman M, Petrovic M.

Chemosphere. 2018 Jun;200:397-404. doi: 10.1016/j.chemosphere.2018.02.095. Epub 2018 Feb 17.

9.

Multinucleated giant myeloma cells after failure of daratumumab therapy.

Guijarro F, Rozman M, Matutes E.

Br J Haematol. 2018 May;181(4):432. doi: 10.1111/bjh.15139. Epub 2018 Feb 22. No abstract available.

PMID:
29468644
10.

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression.

Fernández de Larrea C, Isola I, Pereira A, Cibeira MT, Magnano L, Tovar N, Rodríguez-Lobato LG, Calvo X, Aróstegui JI, Díaz T, Lozano E, Rozman M, Yagüe J, Bladé J, Rosiñol L.

Leukemia. 2018 Jun;32(6):1427-1434. doi: 10.1038/s41375-018-0013-4. Epub 2018 Feb 2.

PMID:
29463830
11.

Leukoerythroblastosis in a Young Child with Severe Malaria and Superimposed Gram Negative Infection.

Varo R, Sitoe A, Cossa A, Ordi J, Rozman M, Bassat Q.

J Trop Pediatr. 2018 Dec 1;64(6):553-556. doi: 10.1093/tropej/fmx101.

PMID:
29272534
12.

The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.

Martínez-Trillos A, Pinyol M, Delgado J, Aymerich M, Rozman M, Baumann T, González-Díaz M, Hernández JM, Alcoceba M, Muntañola A, Terol MJ, Navarro B, Giné E, Jares P, Beà S, Navarro A, Colomer D, Nadeu F, Colado E, Payer AR, García-Cerecedo T, Puente XS, López-Otin C, Campo E, López-Guillermo A, Villamor N.

Leuk Lymphoma. 2018 Oct;59(10):2318-2326. doi: 10.1080/10428194.2017.1397660. Epub 2017 Nov 8.

PMID:
29115891
13.

Effects of chronic pollution and water flow intermittency on stream biofilms biodegradation capacity.

Rožman M, Acuña V, Petrović M.

Environ Pollut. 2018 Feb;233:1131-1137. doi: 10.1016/j.envpol.2017.10.019. Epub 2017 Oct 26.

PMID:
29102172
14.

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.

Nadeu F, Clot G, Delgado J, Martín-García D, Baumann T, Salaverria I, Beà S, Pinyol M, Jares P, Navarro A, Suárez-Cisneros H, Aymerich M, Rozman M, Villamor N, Colomer D, González M, Alcoceba M, Terol MJ, Navarro B, Colado E, Payer ÁR, Puente XS, López-Otín C, López-Guillermo A, Enjuanes A, Campo E.

Leukemia. 2018 Mar;32(3):645-653. doi: 10.1038/leu.2017.291. Epub 2017 Sep 19.

15.

Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report.

Podlipnik S, Guijarro F, Combalia A, To-Figueras J, Badenas C, Costa D, Rozman M, Jorge S, Aguilera P, Gaya A.

Br J Dermatol. 2018 Aug;179(2):486-490. doi: 10.1111/bjd.15927. Epub 2018 Mar 2.

PMID:
28865079
16.

Age Reduces Microvascular Function in the Leg Independent of Physical Activity.

Tonson A, Noble KE, Meyer RA, Rozman MR, Foley KT, Slade JM.

Med Sci Sports Exerc. 2017 Aug;49(8):1623-1630. doi: 10.1249/MSS.0000000000001281.

17.

Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.

Fabris D, Rožman M, Sajko T, Vukelić Ž.

Biochimie. 2017 Jun;137:56-68. doi: 10.1016/j.biochi.2017.03.001. Epub 2017 Mar 10.

PMID:
28286312
18.

Bquant - Novel script for batch quantification of LCMS data.

Rožman M, Petrović M.

MethodsX. 2016 Sep 14;3:520-524. eCollection 2016.

19.

[Leptomeningeal gliomatosis].

Rodríguez-Lobato LG, Gómez-Galván JB, Martínez Hernández D, Rozman M.

Med Clin (Barc). 2016 Sep 16;147(6):279. doi: 10.1016/j.medcli.2015.12.018. Epub 2016 Mar 5. Spanish. No abstract available.

PMID:
26961392
20.

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Nadeu F, Delgado J, Royo C, Baumann T, Stankovic T, Pinyol M, Jares P, Navarro A, Martín-García D, Beà S, Salaverria I, Oldreive C, Aymerich M, Suárez-Cisneros H, Rozman M, Villamor N, Colomer D, López-Guillermo A, González M, Alcoceba M, Terol MJ, Colado E, Puente XS, López-Otín C, Enjuanes A, Campo E.

Blood. 2016 Apr 28;127(17):2122-30. doi: 10.1182/blood-2015-07-659144. Epub 2016 Feb 2.

21.

Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma.

Nomdedeu M, Lara-Castillo MC, Etxabe A, Cornet-Masana JM, Pratcorona M, Díaz-Beyá M, Calvo X, Rozman M, Costa D, Esteve J, Risueño RM.

Cancer Cell Int. 2015 Dec 21;15:122. doi: 10.1186/s12935-015-0272-3. eCollection 2015.

22.

CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.

Baumann T, Delgado J, Santacruz R, Martínez-Trillos A, Rozman M, Aymerich M, López C, Costa D, Carrió A, Villamor N, Montserrat E.

Br J Haematol. 2016 Jan;172(1):48-55. doi: 10.1111/bjh.13788. Epub 2015 Nov 12.

PMID:
26559905
23.

Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.

Rivas-Delgado A, Matutes E, Rozman M.

Br J Haematol. 2016 Feb;172(4):495. doi: 10.1111/bjh.13813. Epub 2015 Oct 12. No abstract available.

PMID:
26457576
24.

Characterization and Modeling of the Collision Induced Dissociation Patterns of Deprotonated Glycosphingolipids: Cleavage of the Glycosidic Bond.

Rožman M.

J Am Soc Mass Spectrom. 2016 Jan;27(1):91-8. doi: 10.1007/s13361-015-1247-2. Epub 2015 Aug 22.

PMID:
26297186
25.

Non-coding recurrent mutations in chronic lymphocytic leukaemia.

Puente XS, Beà S, Valdés-Mas R, Villamor N, Gutiérrez-Abril J, Martín-Subero JI, Munar M, Rubio-Pérez C, Jares P, Aymerich M, Baumann T, Beekman R, Belver L, Carrio A, Castellano G, Clot G, Colado E, Colomer D, Costa D, Delgado J, Enjuanes A, Estivill X, Ferrando AA, Gelpí JL, González B, González S, González M, Gut M, Hernández-Rivas JM, López-Guerra M, Martín-García D, Navarro A, Nicolás P, Orozco M, Payer ÁR, Pinyol M, Pisano DG, Puente DA, Queirós AC, Quesada V, Romeo-Casabona CM, Royo C, Royo R, Rozman M, Russiñol N, Salaverría I, Stamatopoulos K, Stunnenberg HG, Tamborero D, Terol MJ, Valencia A, López-Bigas N, Torrents D, Gut I, López-Guillermo A, López-Otín C, Campo E.

Nature. 2015 Oct 22;526(7574):519-24. doi: 10.1038/nature14666. Epub 2015 Jul 22.

PMID:
26200345
26.

Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3.

Raya JM, Martín-Santos T, Luño E, Sanzo C, Perez-Sirvent ML, Such E, Navarro JT, Millá F, Alonso E, Domingo A, Rozman M, Díaz-Beva M, Batlle A, González-de-Villambrosia S, Tuset E, Vallespí T, Ortega M, Bermejo A, Martín-Ramos M, Peri V, Solé F, Florensa L; Grupo Español de Citología Hematológica (GECH), Working Group into the Sociedad Española de Hematología y Hemoterapia (SEHH).

Hematology. 2015 Sep;20(8):435-441. doi: 10.1179/1607845415Y.0000000003. Epub 2015 Feb 13.

PMID:
25680074
27.

Combined antitumor effects of bee venom and cisplatin on human cervical and laryngeal carcinoma cells and their drug resistant sublines.

Gajski G, Čimbora-Zovko T, Rak S, Rožman M, Osmak M, Garaj-Vrhovac V.

J Appl Toxicol. 2014 Dec;34(12):1332-41.

PMID:
25493319
28.

Database and data analysis application for structural characterization of gangliosides and sulfated glycosphingolipids by negative ion mass spectrometry.

Rožman M, Fabris D, Mrla T, Vukelić Ž.

Carbohydr Res. 2014 Dec 5;400:1-8. doi: 10.1016/j.carres.2014.06.029. Epub 2014 Jul 10.

PMID:
25299937
29.

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.

Queirós AC, Villamor N, Clot G, Martinez-Trillos A, Kulis M, Navarro A, Penas EM, Jayne S, Majid A, Richter J, Bergmann AK, Kolarova J, Royo C, Russiñol N, Castellano G, Pinyol M, Bea S, Salaverria I, López-Guerra M, Colomer D, Aymerich M, Rozman M, Delgado J, Giné E, González-Díaz M, Puente XS, Siebert R, Dyer MJ, López-Otín C, Rozman C, Campo E, López-Guillermo A, Martín-Subero JI.

Leukemia. 2015 Mar;29(3):598-605. doi: 10.1038/leu.2014.252. Epub 2014 Aug 25.

PMID:
25151957
30.

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.

Baumann T, Delgado J, Santacruz R, Martínez-Trillos A, Royo C, Navarro A, Pinyol M, Rozman M, Pereira A, Villamor N, Aymerich M, López C, Carrió A, Montserrat E.

Haematologica. 2014 Oct;99(10):1599-604. doi: 10.3324/haematol.2014.107326. Epub 2014 Jun 27.

31.

XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells.

Moreno-Martínez D, Nomdedeu M, Lara-Castillo MC, Etxabe A, Pratcorona M, Tesi N, Díaz-Beyá M, Rozman M, Montserrat E, Urbano-Ispizua A, Esteve J, Risueño RM.

Oncotarget. 2014 Jun 30;5(12):4337-46.

32.

Predictors of language lateralization in temporal lobe epilepsy.

Stewart CC, Swanson SJ, Sabsevitz DS, Rozman ME, Janecek JK, Binder JR.

Neuropsychologia. 2014 Jul;60:93-102. doi: 10.1016/j.neuropsychologia.2014.05.021. Epub 2014 Jun 4.

33.

Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.

Rozman M, Navarro JT, Arenillas L, Aventín A, Giménez T, Alonso E, Perea G, Camós M, Navarrete M, Tuset E, Florensa L, Millá F, Nomdedéu J, de la Banda E, Díaz-Beyá M, Pratcorona M, Garrido A, Navarro B, Brunet S, Sierra J, Esteve J; Grup Català de Citologia Hematològica and Spanish CETLAM Group (Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas).

Ann Hematol. 2014 Oct;93(10):1695-703. doi: 10.1007/s00277-014-2100-6. Epub 2014 May 14.

PMID:
24824767
34.

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome.

Martínez-Trillos A, Pinyol M, Navarro A, Aymerich M, Jares P, Juan M, Rozman M, Colomer D, Delgado J, Giné E, González-Díaz M, Hernández-Rivas JM, Colado E, Rayón C, Payer AR, Terol MJ, Navarro B, Quesada V, Puente XS, Rozman C, López-Otín C, Campo E, López-Guillermo A, Villamor N.

Blood. 2014 Jun 12;123(24):3790-6. doi: 10.1182/blood-2013-12-543306. Epub 2014 Apr 29.

35.

Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report.

Raya JM, Montes-Moreno S, Acevedo A, Ferrández A, Fraga M, García JF, García M, Mayordomo-Aranda E, Menárguez J, Besses C, Calzada R, Rozman M.

J Clin Pathol. 2014 Jul;67(7):620-5. doi: 10.1136/jclinpath-2014-202246. Epub 2014 Apr 7.

PMID:
24711513
36.

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.

Santacruz R, Villamor N, Aymerich M, Martínez-Trillos A, López C, Navarro A, Rozman M, Beà S, Royo C, Cazorla M, Colomer D, Giné E, Pinyol M, Puente XS, López-Otín C, Campo E, López-Guillermo A, Delgado J.

Haematologica. 2014 May;99(5):873-80. doi: 10.3324/haematol.2013.099796. Epub 2014 Apr 3.

37.

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.

Ferreira PG, Jares P, Rico D, Gómez-López G, Martínez-Trillos A, Villamor N, Ecker S, González-Pérez A, Knowles DG, Monlong J, Johnson R, Quesada V, Djebali S, Papasaikas P, López-Guerra M, Colomer D, Royo C, Cazorla M, Pinyol M, Clot G, Aymerich M, Rozman M, Kulis M, Tamborero D, Gouin A, Blanc J, Gut M, Gut I, Puente XS, Pisano DG, Martin-Subero JI, López-Bigas N, López-Guillermo A, Valencia A, López-Otín C, Campo E, Guigó R.

Genome Res. 2014 Feb;24(2):212-26. doi: 10.1101/gr.152132.112. Epub 2013 Nov 21.

38.

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

Beà S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, Giné E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizán P, Di Croce L, Puente DA, López-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Martínez A, Valera A, Martín-Subero JI, Amador V, Hernández L, Rozman M, Enjuanes A, Forcada P, Muntañola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hernández-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, López-Guillermo A, López-Otín C, Puente XS, Campo E.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18250-5. doi: 10.1073/pnas.1314608110. Epub 2013 Oct 21.

39.

Structural analysis of brain ganglioside acetylation patterns in mice with altered ganglioside biosynthesis.

Mlinac K, Fabris D, Vukelić Z, Rožman M, Heffer M, Bognar SK.

Carbohydr Res. 2013 Dec 15;382:1-8. doi: 10.1016/j.carres.2013.09.007. Epub 2013 Sep 27.

PMID:
24140892
40.

Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administration.

Delgado J, Ghita G, Baumann T, Santacruz R, Dlouhy I, Aymerich M, Rozman M, Creus N, Pereira A, Montserrat E.

Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):73-9. doi: 10.1016/j.clml.2013.08.003. Epub 2013 Oct 12.

PMID:
24126217
41.

Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.

López C, Delgado J, Costa D, Villamor N, Navarro A, Cazorla M, Gómez C, Arias A, Muñoz C, Cabezas S, Baumann T, Rozman M, Aymerich M, Colomer D, Pereira A, Cobo F, López-Guillermo A, Campo E, Carrió A.

Genes Chromosomes Cancer. 2013 Oct;52(10):920-7. doi: 10.1002/gcc.22087. Epub 2013 Jul 26.

PMID:
23893575
42.

Acquired Fanconi syndrome secondary to monoclonal gammopathies: a case series from a single center.

Magnano L, Fernández de Larrea C, Cibeira MT, Rozman M, Tovar N, Rovira M, Rosiñol L, Bladé J.

Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):614-8. doi: 10.1016/j.clml.2013.04.008. Epub 2013 Jun 15. No abstract available.

PMID:
23773452
43.

Molecular determinants of human dipeptidyl peptidase III sensitivity to thiol modifying reagents.

Karačić Z, Špoljarić J, Rožman M, Abramić M.

Biol Chem. 2012 Dec;393(12):1523-32.

PMID:
23667907
44.

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.

Broséus J, Alpermann T, Wulfert M, Florensa Brichs L, Jeromin S, Lippert E, Rozman M, Lifermann F, Grossmann V, Haferlach T, Germing U, Luño E, Girodon F, Schnittger S; MPN and MPNr-EuroNet (COST Action BM0902).

Leukemia. 2013 Sep;27(9):1826-31. doi: 10.1038/leu.2013.120. Epub 2013 Apr 18.

PMID:
23594705
45.

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.

Villamor N, Conde L, Martínez-Trillos A, Cazorla M, Navarro A, Beà S, López C, Colomer D, Pinyol M, Aymerich M, Rozman M, Abrisqueta P, Baumann T, Delgado J, Giné E, González-Díaz M, Hernández JM, Colado E, Payer AR, Rayon C, Navarro B, José Terol M, Bosch F, Quesada V, Puente XS, López-Otín C, Jares P, Pereira A, Campo E, López-Guillermo A.

Leukemia. 2013 Apr;27(5):1100-6. doi: 10.1038/leu.2012.357. Epub 2012 Dec 6.

PMID:
23295735
46.

Refining the diagnosis and prognostic categorization of acute myeloid leukemia patients with an integrated use of cytogenetic and molecular studies.

Costa D, Vidal A, Carrió A, Muñoz C, Arias A, Gómez C, Berneaga D, Colomer D, Rozman M, Pratcorona M, Torrebadell M, Díaz-Beyá M, Esteve J, Campo E.

Acta Haematol. 2013;129(2):65-71. doi: 10.1159/000343616. Epub 2012 Nov 15.

PMID:
23154527
47.

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.

Kulis M, Heath S, Bibikova M, Queirós AC, Navarro A, Clot G, Martínez-Trillos A, Castellano G, Brun-Heath I, Pinyol M, Barberán-Soler S, Papasaikas P, Jares P, Beà S, Rico D, Ecker S, Rubio M, Royo R, Ho V, Klotzle B, Hernández L, Conde L, López-Guerra M, Colomer D, Villamor N, Aymerich M, Rozman M, Bayes M, Gut M, Gelpí JL, Orozco M, Fan JB, Quesada V, Puente XS, Pisano DG, Valencia A, López-Guillermo A, Gut I, López-Otín C, Campo E, Martín-Subero JI.

Nat Genet. 2012 Nov;44(11):1236-42. doi: 10.1038/ng.2443. Epub 2012 Oct 14.

PMID:
23064414
48.

Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.

Díaz-Beyá M, Navarro A, Ferrer G, Díaz T, Gel B, Camós M, Pratcorona M, Torrebadell M, Rozman M, Colomer D, Monzo M, Esteve J.

Leukemia. 2013 Mar;27(3):595-603. doi: 10.1038/leu.2012.278. Epub 2012 Oct 1.

PMID:
23022987
49.

Retreatment with purine analogs in patients with chronic lymphocytic leukemia.

Dlouhy I, Ghita G, Baumann T, Gine E, Villamor N, Rozman M, Martinez-Trillos A, Lopez-Guillermo A, Delgado J.

Leuk Res. 2012 Dec;36(12):1521-5. doi: 10.1016/j.leukres.2012.08.020. Epub 2012 Aug 28.

PMID:
22938831
50.

Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations.

López C, Delgado J, Costa D, Conde L, Ghita G, Villamor N, Navarro A, Cazorla M, Gómez C, Arias A, Muñoz C, Baumann T, Rozman M, Aymerich M, Colomer D, Cobo F, Campo E, López-Guillermo A, Montserrat E, Carrió A.

Genes Chromosomes Cancer. 2012 Sep;51(9):881-9. doi: 10.1002/gcc.21972. Epub 2012 May 23.

PMID:
22619094

Supplemental Content

Loading ...
Support Center